EC, EMA and HMA publish joint Q&A intended to guide Complex Clinical Trials (Cell and Gene Therapy Catapult – Regulatory Round-up – Juin 2022)
On 2 June, the European Commission (EC), the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) published a joint Q&A intended to guide complex clinical trials (CCTs).
See all of Catapult’s Regulatory Round-up for June 2022 here.
Published on the 1st of July 2022.
OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (27 octobre 2022). EC, EMA and HMA publish joint Q&A intended to guide Complex Clinical Trials (Cell and Gene Therapy Catapult – Regulatory Round-up – Juin 2022). ELSIBI. Consulté le 5 mars 2026 à l’adresse https://doi.org/10.58079/o641





